Kenichi Ishizawa

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Epstein Barr Virus

Hodgkin Lymphoma

Diffuse Large B Cell Lymphoma

Top Venues

Japanese journal of clinical oncology

International journal of hypertension

Cancer chemotherapy and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Wataru Munakata, Koji Izutsu, Yuko Mishima, Hirokazu Nagai, Yuko Ishihara, Junji Suzumiya, Yuzuru Kanakura, Toshihiro Nanki, Takeshi Miyake, Atsuko Kawasaki, Tatsuya Yoshinaga, Kenichi Ishizawa
Dose-escalation part of Phase I study of single-agent mosunetuzumab in Japanese patients with relapsed/refractory B-cell non-Hodgkin lymphoma. Japanese journal of clinical oncology (2023)
Tadao Ishida, Shigeki Ito, Junji Tanaka, Michihiro Uchiyama, Yawara Kawano, Philippe Moreau, Thomas Martin, Marie-Laure Risse, Keisuke Tada, Kenshi Suzuki, Kenichi Ishizawa
Isatuximab plus carfilzomib and dexamethasone in Japanese patients with relapsed multiple myeloma: subgroup analysis of the randomized, open label, phase 3 IKEMA study. Japanese journal of clinical oncology 52 (12) (2022)
Kentaro Watanabe, Noe Takakubo, Taro Saigusa, Akiko Nagasawa, Midori Yamana, Midori Ojima, Wataru Kameda, Shinji Susa, Kenichi Ishizawa, Hisamitsu Ishihara
Fibrosis-4 Index Is Closely Associated with Arterial Damage and Future Risk of Coronary Heart Disease in Type 2 Diabetes. International journal of hypertension 2022 (2022)
Kenichi Ishizawa, Masahiro Yokoyama, Harumi Kato, Kazuhito Yamamoto, Masanori Makita, Kiyoshi Ando, Yasunori Ueda, Yoshimichi Tachikawa, Youko Suehiro, Mitsutoshi Kurosawa, Yoshihiro Kameoka, Hirokazu Nagai, Nobuhiko Uoshima, Takayuki Ishikawa, Michihiro Hidaka, Yoshikiyo Ito, Atae Utsunomiya, Koji Fukushima, Michinori Ogura
A phase I/II study of 10-min dosing of bendamustine hydrochloride (rapid infusion formulation) in patients with previously untreated indolent B-cell non-Hodgkin lymphoma, mantle cell lymphoma, or relapsed/refractory diffuse large B-cell lymphoma in Japan. Cancer chemotherapy and pharmacology 90 (1) (2022)